People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Knopp Neurosciences Inc. | — | Biotechnology | Series C | $72.9M | $2.5B | 2009 |
Evan T. Ingersoll at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Evan T. Ingersoll on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gregory T. Hebrank | 1 | 4 |
| Jeffrey S. McCormick | 1 | 4 |
| Michael E. Bozik | 1 | 3 |
| Evan W. Ingersoll | 1 | 2 |
| Valentin K. Gribkoff | 1 | 2 |
| Benjamin A. Gomez | 1 | 2 |
| Thomas W. Petzinger, Jr. | 1 | 2 |
| Ben S. Gomez | 1 | 1 |
| Thomas, Jr. T. Petzinger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.